4.5 (636) In stock
The Quebec-based pharmacy company had $47.8 million or 26 cents per share of net income in its fourth quarter, ended March 4 — down seven per cent from the comparable period last year.
China's Industrial Profits Jump Though Deflation Woes Linger - Bloomberg
Solved Assume that you have been hired as a consultant by
One bad quarter for commodity prices won't hurt our company: Birchcliff Energy CEO - Video - BNN
Novo Nordisk Sales Soar, Fortifying Grip on Obesity Drug Market - Bloomberg
Obesity Drug WeGovy to Drive Up Profits at Novo Nordisk - Bloomberg
How Not to Negotiate a $6.1 Billion Deal - Bloomberg
Home Depot Sales Drop for Fifth Straight Quarter on Weak Demand - BNN Bloomberg
Grocers brace for generic drug deal; Loblaw stock downgraded by Desjardins - BNN Bloomberg
Burger King owner's fourth-quarter sales outpace expectations - BNN Bloomberg
